Sano is building a small, wearable sensor that can capture and transmit blood chemistry data continuously to virtually any device. The company will liberate this data to a third-party development and analytical platform called the API for the bloodstream.

about the company


Co-Founder at Sano Intelligence.

Health tech entrepreneur, web / mobile developer, former venture capital investor

Sano in the press

June 22, 2015

Sano Raises $10.25M in Seed Funding

Sano, a San Francisco, CA-based maker of a wearable device that monitors metabolic activity, raised $10.25m in seed funding. The round was led by True Ventures and Intel Capital, with participation from Felicis Ventures, Elevation Capital, Floodgate, and Rock Health. Led by Founder Ashwin Pushpala, Sano has developed a biometric sensor that aims to help people understand what’s happening inside their bodies through continuously monitoring important markers in their bodies’ chemistry. Still in stealth mode, the company’s team comes from leading technology companies (Apple, Google, Samsung, Fitbit) and academic institutions (Stanford, UC Berkeley, MIT). The company intends to use the funds to continue to advance the platform and expand operations.

June 19, 2015

With $10 Million In Seed, Sano Is Building A Metabolic Health Tracker

Since physical activity is only one element of health, Sano is building a wearable sensor that measures metabolic activity. Powering Sano is $10.25 million in seed funding from Fitbit backer True Ventures and Intel Capital. Diabetics have to test blood glucose levels many times per day, which means pricking a finger for a drop of blood to push against a test strip. How exactly a non-invasive blood glucose sensor would work is unclear, and Pushpala isn’t disclosing any specifics about Sano’s first product. Fitbit took a wearable activity tracker and built a $6 billion dollar company — Sano, a stealthy startup out of San Francisco, wants to do better.